2522.HK
Jiangxi Rimag Group, which provides medical imaging services, opened at HK$15 in their Friday trading debut, 0.1% higher than their IPO price of HK$14.98.

The Latest: Jiangxi Rimag Group Co. Ltd. (2522.HK), which provides medical imaging services, opened at HK$15 in their Friday trading debut, 0.1% higher than their IPO price of HK$14.98, giving the company a market capitalization of about HK$3 billion ($385 million).

Looking Up: The local portion of the offering was subscribed by 17,855 investors and was oversubscribed by about 336.3 times.

Take Note: Despite a favorable response to subscription, the stock was priced at only HK$14.98, close to the lower end of its HK$14.60 to HK$16.80 IPO price range.

Digging Deeper: Rimag Group operates its own medical imaging centers or helps partners run their centers. Since its launch in 2014, the company has built 97 imaging centers in 17 provinces, autonomous regions and municipalities in China, establishing a presence in major cities as well as 59 regions at county level. The company first submitted an unsuccessful listing application to the Hong Kong Stock Exchange in May last year, filed again in November and passed the listing hearing in May this year.

Market Reaction: Rimag’s stock continued to rise after the open and was up 2.9% at HK$15.42 by the midday trading break on Friday.  

Translation by A. Au

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Chifeng Gold's next growth curve: Rare earth

Chifeng Gold chases new glitter in rare earths

The company currently gets 90% of its revenue from gold, but is expanding into copper and rare earths to tap anticipated future demand Key Takeaways: Chifeng Gold’s profit surged 141%…
Teway makes seasonings

Sichuan Teway spices up Hong Kong’s hot IPO market

The maker of ready-to-cook and hotpot pre-mixed seasonings has filed to list in Hong Kong, positioning itself as a consolidator in China’s huge seasonings market Key Takeaways: Sichuan Teway has…